Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OMAB | MAT |
|---|---|---|
| Price | $94.98 | $16.05 |
| Change today | ▲ 0.84% | ▲ 5.11% |
| Market cap | $4.58B | $4.59B |
| Return, 3 months | -11.4% | +19.6% |
| Return, year to date | -10.1% | -19.1% |
| Return, 1 year | -1.6% | -11.2% |
| P/E (TTM) | 15.3 | 12.0 |
| P/B | 9.1 | 2.3 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 5.77% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +23.7% | +13.0% |
| Analyst buy share | 50% | 60% |
| RSI (14) | 37 | 70 |
| 30-day volatility | 23.3% | 60.6% |
| Max drawdown, 1 year | -28.2% | -42.9% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
